C83.71
Burkitt lymphoma, lymph nodes of head, face, and neck
Clinical Classification Guidelines
Medical Intelligence & Overview
Burkitt lymphoma is a fast-growing type of non-Hodgkin lymphoma that originates in the lymphatic system. This specific form, classified under ICD-10 code C83.71, affects the lymph nodes located in the head, face, and neck. Although it is rare, it is known for its aggressive behavior and rapid progression. Early detection and treatment are crucial for improving outcomes. This guide aims to provide a clear understanding of what Burkitt lymphoma in these regions entails, including its causes, symptoms, diagnosis, and treatment options.
Causes & Symptoms
Clinical Causes: Infection with the Epstein-Barr virus (EBV), which is associated with some cases of Burkitt lymphoma Genetic factors that may predispose individuals to lymphoma development Immunodeficiency states, such as HIV/AIDS or post-transplant immunosuppression Additional genetic mutations that lead to abnormal growth of lymphocyte cells
Key Symptoms: Swelling or a noticeable lump in the neck, jaw, or face Unexplained weight loss over a short period Fever that persists without an obvious cause Night sweats and fatigue Difficulty swallowing or breathing if the tumor presses on surrounding structures Pain or tenderness in the affected areas
Diagnostic & Treatment
Diagnosis Path: Diagnosing Burkitt lymphoma usually involves a combination of physical examination, imaging studies, and laboratory tests. The process includes: - Physical assessment to identify enlarged lymph nodes - Imaging techniques such as CT scans or MRI to determine the extent of affected areas - Biopsy of the lymph node or affected tissue to examine cellular details under a microscope - Laboratory tests, including blood counts and markers, - Possible tests for infectious agents like EBV - Staging procedures to assess the spread of the disease, which help guide treatment planning
Treatment Protocols: Treatment strategies for Burkitt lymphoma are often aggressive and may include a combination of therapies: - Chemotherapy regimens designed to target rapidly dividing cells - Immunotherapy to boost the immune response against the cancer - Targeted therapy aimed at specific molecules involved in tumor growth - In some cases, surgery to remove accessible tumors - Supportive care to manage side effects and improve quality of life Given the aggressive nature of this lymphoma, treatment typically requires prompt initiation under the guidance of a specialized medical team.
Clinical Advice & FAQs
Billing Guidance
Is C83.71 a billable ICD-10 code?
Yes, C83.71 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.71?
Clinical documentation must specify the nature of Burkitt lymphoma, lymph nodes of head, face, and neck and any associated comorbidities for accurate reporting.
Cite this Clinical Reference